Christobel E. Selecky, MA

Alzheimer disease and other dementias (ADOD) have a substantial impact on the prevalence and costs of certain comorbid conditions compared with matched beneficiaries without ADOD.

Five years after the implementation of the first provisions of the Affordable Care Act and 5 months after the close of the first open enrollment period for the Health Insurance Marketplaces, we are starting to be able to measure the impact of the law.